Published in CNS Drugs on March 01, 2014
Triptans and third nerve paresis: a case series of three patients. Eye (Lond) (2016) 0.75
Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension (2006) 2.39
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension (2005) 1.89
Aliskiren accumulates in Renin secretory granules and binds plasma prorenin. Hypertension (2008) 1.61
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. J Hypertens (2003) 1.54
Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension (2006) 1.51
Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol (2009) 1.47
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol (2004) 1.39
Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens (2007) 1.35
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation (2004) 1.31
5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci (2008) 1.23
K+-induced natriuresis is preserved during Na+ depletion and accompanied by inhibition of the Na+-Cl- cotransporter. Am J Physiol Renal Physiol (2013) 1.21
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation (2005) 1.14
Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway. Pflugers Arch (2012) 1.13
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J (2009) 1.00
Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J Hypertens (2011) 1.00
Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther (2006) 0.99
Microbiological examination of donated human cardiac tissue in heart valve banking. Eur J Cardiothorac Surg (2009) 0.98
Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Lett (2008) 0.97
Basic mechanisms of migraine and its acute treatment. Pharmacol Ther (2012) 0.97
Intracranial and extracranial arteries in migraine. Lancet Neurol (2013) 0.96
Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. Am J Physiol Renal Physiol (2004) 0.96
Cardiovascular alterations after spinal cord injury: an overview. Curr Med Chem Cardiovasc Hematol Agents (2004) 0.95
Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity. Eur J Pharmacol (2005) 0.95
Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors? J Hypertens (2010) 0.94
Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. Hypertension (2011) 0.94
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J (2008) 0.93
Current and prospective pharmacological targets in relation to antimigraine action. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.92
Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol (2002) 0.91
Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II. Hypertension (2005) 0.91
Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.91
Nucleotide excision DNA repair is associated with age-related vascular dysfunction. Circulation (2012) 0.90
Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs. JACC Cardiovasc Interv (2010) 0.90
Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90. Biochim Biophys Acta (2010) 0.89
Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone? Hypertension (2006) 0.89
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Eur J Pharmacol (2006) 0.89
Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes. Am J Physiol Heart Circ Physiol (2011) 0.88
(Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cells. Am J Physiol Renal Physiol (2013) 0.88
Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur J Pharmacol (2003) 0.88
Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects. Pharmacol Ther (2010) 0.88
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia (2010) 0.88
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries. Eur J Pharmacol (2009) 0.87
The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy. Eur J Hum Genet (2012) 0.87
ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? Arterioscler Thromb Vasc Biol (2003) 0.87
Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors. Br J Pharmacol (2003) 0.87
AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease. Am J Physiol Renal Physiol (2012) 0.86
Mast cell degranulation mediates bronchoconstriction via serotonin and not via renin release. Eur J Pharmacol (2010) 0.86
Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J Headache Pain (2014) 0.85
Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats. J Hypertens (2010) 0.85
Characterisation of CGRP receptors in the human isolated middle meningeal artery. Life Sci (2006) 0.85
Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding? Front Biosci (2008) 0.85
The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci (2007) 0.85
Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin? J Hypertens (2013) 0.84
Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol (2003) 0.83
Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br J Pharmacol (2004) 0.83
Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition. Hypertension (2014) 0.82
The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype. Br J Pharmacol (2002) 0.82
5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. Eur J Pharmacol (2004) 0.82
Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats. Basic Clin Pharmacol Toxicol (2004) 0.82
Pharmacological evidence that Ca²+ channels and, to a lesser extent, K+ channels mediate the relaxation of testosterone in the canine basilar artery. Steroids (2010) 0.82
Further characterization of the 5-HT1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT1B and 5-HT1D subtypes. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.82
Mediators of bradykinin-induced vasorelaxation in human coronary microarteries. Hypertension (2003) 0.81
Cognitive functioning early after surgery of gliomas in eloquent areas. J Neurosurg (2012) 0.81
Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br J Pharmacol (2002) 0.81
The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats. J Hypertens (2013) 0.81
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. Hypertension (2004) 0.81
Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade. J Hypertens (2006) 0.80
A61603-induced contractions of the porcine meningeal artery are mediated by alpha1- and alpha2-adrenoceptors. Basic Clin Pharmacol Toxicol (2007) 0.80
Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? Br J Pharmacol (2005) 0.80
Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opin Pharmacother (2013) 0.80
Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. Eur J Pharmacol (2006) 0.80
A twofold genetic increase of ACE expression has no effect on the development of spontaneous hypertension. Am J Hypertens (2008) 0.79
Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache (2007) 0.79
Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst (2013) 0.79
Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.79
The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors. Pharmacol Ther (2010) 0.79
Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats. Life Sci (2004) 0.79